Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Downgrades Oncorus to Neutral

HC Wainwright & Co. Downgrades Oncorus to Neutral

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Oncorus (NASDAQ:ONCR) from Buy to Neutral.

byBenzinga Newsdesk

December 6, 2022

1 minute read

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Oncorus (NASDAQ:ONCR) from Buy to Neutral.

Bailout for First Republic? US Officials In Discussion For Bank’s Rescue: Report

By Akanksha Bakshi

April 28, 10:16 AM

First Republic Bank (NYSE: FRC) is under the government's scanner for rescue as the private sector delays settlements.

FRC

U.S. Retail Sales Likely To Recover In June, Here’s The Major Macro Issues For Friday

By Lisa Levin

July 15, 5:40 AM

U.S. stocks closed mixed on Thursday following downbeat earnings results from JPMorgan Chase & Co. (NYSE: JPM) and Morgan Stanley (NYSE: MS).

JPM

Investor Optimism Decreases; Dow Tumbles Over 400 Points

By Avi Kapoor

May 30, 2:01 AM

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index…

AAP

Evaxion Expands Preclinical Bacterial Vaccine Pipeline In Collaboration With Leading Pharmaceutical Company

By Benzinga Newsdesk

September 18, 8:24 AM

AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine is currently available Evaxion's proprietary AI-platforms EDEN™ and RAVEN™ will be utilized for rapid

EVAX

HC Wainwright & Co. Downgrades Oncorus to Neutral

Related Posts

Bailout for First Republic? US Officials In Discussion For Bank’s Rescue: Report

U.S. Retail Sales Likely To Recover In June, Here’s The Major Macro Issues For Friday

Investor Optimism Decreases; Dow Tumbles Over 400 Points

Evaxion Expands Preclinical Bacterial Vaccine Pipeline In Collaboration With Leading Pharmaceutical Company